These reports can be easily shared with your healthcare provider to optimize your treatment plan
Even though its one of the older members of the family, Saxenda's role in the GLP-1 receptor agonist family is not to be underestimated, as it offers an alternative for patients who may not be suitable candidates for Ozempic or Wegovy
At Smart Choice Medical Clinic, we dont believe in one-size-fits-all medicine
If you want results, use injectable
In addition, the FDA maintains a system of postmarketing surveillance and risk assessment programs to identify and evaluate adverse events that did not appear during the drug development process
There is also other early research that shows that GLP-1 can be an effective treatment for drug or alcohol addiction, so we will likely see the medication be used beyond diabetes and obesity in the future.